skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
10 - Progress in achieving proof of concept for p38 kinase inhibitors
Target Validation in Drug Discovery, 2007, p.179-198
2007 Elsevier Inc. ;ISBN: 0123693934 ;ISBN: 9780123693938 ;DOI: 10.1016/B978-012369393-8/50011-0
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
10 - Progress in achieving proof of concept for p38 kinase inhibitors
Author:
Adams, Jerry L
;
Lee, John C.
Is Part Of:
Target Validation in Drug Discovery, 2007, p.179-198
Description:
The availability of selective p38 inhibitors provides the critical tools required to delineate the role that protein kinases play in signaling pathways. Activation of p38 has been observed in various organisms as a response to many stimuli. The p38α orthologs in yeast, worm, and frog have been implicated in osmoregulation, stress responses, and cell-cycle regulation. Downstream substrates of p38 MAP kinases are MAPKAPK2 and MAPKAPK3, which phosphorylate various substrates—including small heat shock protein 27 (HSP27), lymphocyte-specific protein 1(LSP1), cAMP response element-binding protein (CREB), transcription factor (ATF1), SRF, and tyrosine hydroxylase. The mechanism by which p38 MAP kinase inhibitors suppress expression of inflammatory cytokines has been elusive. The initial focus on p38 inhibitors as potential disease-modifying agents to treat rheumatoid arthritis has expanded to the exploration of psoriasis, Crohn's disease, inflammatory bowel disease, chronic obstructive pulmonary disease, cardiovascular disease, stroke, cardiac hypertrophy, Alzheimer's disease, and vascular injury. The role of MAPKAPK-2 in p38-induced inflammatory cytokine synthesis has been validated in a knock-out mouse.
Publisher:
Elsevier Inc
Language:
English
Identifier:
ISBN: 0123693934
ISBN: 9780123693938
DOI: 10.1016/B978-012369393-8/50011-0
Source:
Ebook Central Academic Complete
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript